BSE Healthcare Stocks - BSE Healthcare Index Companies

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	ROE(%)	P/E	P/BV	EV/ EBITDA	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Cohance Lifesciences Ltd	Q V+ PT	392	7.80%	14,981 Small Cap	1,247 22 Apr, 25	268 09 Mar, 26	13.87	74.28	3.93	33.69	7.51	-3.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	RPG Life Sciences Ltd	Q V+ PT	2,026	6.63%	3,351 Small Cap	2,716 07 Jul, 25	1,731 23 Mar, 26	27.50	16.54	5.82	20.37	11.71	30.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	IOL Chemicals And Pharmaceuticals Ltd	Q V+ PT	91.16	6.62%	2,676 Small Cap	127 19 Sep, 25	60.55 09 May, 25	5.78	23.09	1.51	10.13	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Themis Medicare Ltd	Q V PT	90.25	5.83%	831 Small Cap	179 19 May, 25	65.00 30 Mar, 26	7.37	0.00	2.78	-482.13	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Park Medi World Ltd	Q V PT	216	5.57%	9,338 Small Cap	218 15 Apr, 26	138 18 Dec, 25	6.55	1300.79	10.39	362.06	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Shree Ganesh Remedies Ltd	Q V PT	534	5.26%	685 Small Cap	828 23 Apr, 25	381 27 Jan, 26	16.37	37.87	4.38	18.72	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	3B Blackbio Dx Ltd	Q V PT	1,310	5.10%	1,124 Small Cap	2,020 28 May, 25	1,110 02 Apr, 26	18.95	22.00	3.61	15.47	46.29	132.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Gujarat Themis Biosyn Ltd	Q V+ PT	319	5.08%	3,481 Small Cap	479 27 Oct, 25	226 30 Mar, 26	21.67	72.84	12.57	47.16	12.12	15.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Alembic Pharmaceuticals Ltd	Q V+ PT	785	4.81%	15,429 Small Cap	1,108 30 Jun, 25	635 23 Mar, 26	11.08	24.53	2.83	13.85	7.69	-8.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Concord Biotech Ltd	Q V PT	1,081	4.13%	11,312 Small Cap	2,150 11 Jun, 25	987 02 Apr, 26	21.35	36.20	5.98	23.25	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Kwality Pharmaceuticals Ltd	Q V+ PT	1,747	4.01%	1,813 Small Cap	1,760 17 Apr, 26	666 07 May, 25	16.19	32.05	5.90	17.51	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Supriya Lifescience Ltd	Q V PT	650	3.46%	5,229 Small Cap	831 04 Nov, 25	546 24 Mar, 26	20.73	28.23	4.62	18.64	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Gland Pharma Ltd	Q V PT	1,796	3.44%	29,587 Small Cap	2,130 29 Jul, 25	1,382 02 May, 25	11.53	25.31	2.86	15.25	9.35	7.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Rubicon Research Ltd	Q V+ PT	897	3.06%	14,810 Small Cap	912 17 Apr, 26	571 24 Oct, 25	28.27	88.40	11.45	52.65	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Kopran Ltd	Q V PT	160	3.03%	771 Small Cap	213 12 Jun, 25	107 30 Mar, 26	5.88	38.05	1.80	21.70	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	CORONA Remedies Ltd	Q V+ PT	1,621	2.98%	9,914 Small Cap	1,691 10 Mar, 26	1,337 23 Dec, 25	27.46	66.51	14.16	40.26	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Narayana Hrudayalaya Ltd	Q V+ PT	1,826	2.92%	37,307 Mid Cap	2,372 27 Jun, 25	1,564 30 Mar, 26	24.16	47.90	8.90	24.92	11.88	45.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Natco Pharma Ltd	Q V PT	1,119	2.87%	20,042 Small Cap	1,135 10 Apr, 26	752 09 May, 25	26.69	12.87	2.28	8.21	18.26	32.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Syncom Formulations (India) Ltd	Q V PT	14.34	2.80%	1,348 Small Cap	23.46 28 May, 25	10.21 30 Mar, 26	14.45	19.55	3.41	13.93	17.63	21.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Wockhardt Ltd	Q V+ PT	1,397	2.77%	22,697 Small Cap	1,870 12 Jun, 25	1,087 23 Mar, 26	-1.15	1031.68	4.90	43.33	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Nephrocare Health Services Ltd	Q V+ PT	585	2.53%	5,870 Small Cap	619 27 Feb, 26	445 19 Dec, 25	7.15	171.47	6.49	53.93	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Krishna Institute of Medical Sciences Ltd	Q V PT	682	2.51%	27,283 Small Cap	798 24 Jul, 25	576 27 Jan, 26	14.20	94.64	11.55	55.56	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Onesource Specialty Pharma Ltd	Q V PT	1,540	2.28%	17,659 Small Cap	2,250 18 Jun, 25	1,075 30 Jan, 26	3.04	101.14	2.98	41.44	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Biocon Ltd	Q V PT	358	2.18%	58,061 Mid Cap	425 18 Nov, 25	309 25 Apr, 25	1.61	7846.07	2.15	108.82	2.44	-9.71	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Neuland Laboratories Ltd	Q V+ PT	15,302	2.11%	19,632 Small Cap	19,748 10 Nov, 25	10,598 16 May, 25	14.69	110.09	11.89	57.67	14.13	64.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Artemis Medicare Services Ltd	Q V PT	235	2.07%	3,715 Small Cap	298 18 Nov, 25	203 13 Apr, 26	12.84	38.26	3.17	17.57	10.15	32.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Solara Active Pharma Sciences Ltd	Q V PT	499	2.03%	2,405 Small Cap	734 25 Jul, 25	423 30 Mar, 26	-0.09	0.00	1.94	16.63	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Nectar Lifesciences Ltd	Q V+ PT	12.66	2.01%	246 Small Cap	28.27 28 May, 25	9.20 01 Apr, 26	-11.82	0.00	0.35	-3.22	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Aster DM Healthcare Ltd	Q V+ PT	688	1.95%	35,662 Small Cap	732 23 Oct, 25	493 25 Apr, 25	7.55	109.06	7.75	35.70	-13.71	0.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Emcure Pharmaceuticals Ltd	Q V+ PT	1,670	1.94%	31,666 Small Cap	1,688 17 Apr, 26	950 09 May, 25	11.03	49.57	9.12	27.16	13.02	9.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
31	Morepen Laboratories Ltd	Q V+ PT	41.92	1.92%	2,297 Small Cap	70.40 12 Jun, 25	33.44 30 Mar, 26	9.12	39.71	1.89	17.89	14.44	19.03	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Hikal Ltd	Q V+ PT	192	1.91%	2,369 Small Cap	449 14 May, 25	146 30 Mar, 26	7.16	0.00	1.99	12.39	4.29	-1.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Apollo Hospitals Enterprise Ltd	Q V+ PT	7,699	1.89%	1,10,701 Large Cap	8,099 23 Oct, 25	6,680 28 Jan, 26	15.77	76.68	11.41	42.63	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Innova Captab Ltd	Q V PT	741	1.81%	4,238 Small Cap	1,003 13 Jun, 25	608 02 Mar, 26	11.45	53.20	4.83	28.85	20.74	22.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Fortis Healthcare Ltd	Q V+ PT	890	1.77%	67,172 Mid Cap	1,105 13 Oct, 25	623 09 May, 25	1.59	411.75	7.30	129.95	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Pfizer Ltd	Q V PT	4,954	1.74%	22,664 Small Cap	5,988 16 Jun, 25	4,124 21 Apr, 25	16.58	26.55	5.68	18.36	1.18	5.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Max Healthcare Institute Ltd	Q V PT	1,007	1.62%	97,991 Mid Cap	1,314 04 Jul, 25	904 07 Apr, 26	12.68	69.05	9.46	43.39	46.01	60.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Jupiter Life Line Hospitals Ltd	Q V PT	1,285	1.56%	8,426 Small Cap	1,618 31 Oct, 25	1,152 02 Mar, 26	13.61	45.15	5.41	25.36	18.02	36.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Blue Jet Healthcare Ltd	Q V PT	423	1.50%	7,335 Small Cap	1,028 21 Jul, 25	325 30 Mar, 26	28.99	24.99	5.66	16.96	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Panacea Biotec Ltd	Q V+ PT	358	1.50%	2,193 Small Cap	581 15 May, 25	293 30 Mar, 26	-4.99	0.00	7.71	-134.37	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Hester Biosciences Ltd	Q V+ PT	1,493	1.41%	1,270 Small Cap	2,348 04 Aug, 25	1,251 01 Apr, 26	9.68	35.92	3.54	23.12	11.08	0.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Unichem Laboratories Ltd	Q V PT	351	1.40%	2,470 Small Cap	668 22 May, 25	280 30 Mar, 26	5.91	10.95	0.94	15.16	13.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Aarti Drugs Ltd	Q V+ PT	373	1.40%	3,406 Small Cap	575 21 Jul, 25	319 30 Mar, 26	12.69	16.81	2.26	12.79	5.74	4.42	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Glaxosmithkline Pharmaceuticals Ltd	Q V+ PT	2,452	1.35%	41,535 Mid Cap	3,516 05 Jun, 25	2,218 30 Mar, 26	47.10	40.68	20.73	28.29	3.06	33.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Indoco Remedies Ltd	Q V+ PT	220	1.20%	2,029 Small Cap	348 17 Jul, 25	164 30 Mar, 26	-0.86	0.00	1.90	21.95	6.54	-182.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Dr. Reddys Laboratories Ltd	Q V PT	1,235	1.16%	1,03,114 Mid Cap	1,378 12 Jun, 25	1,121 07 May, 25	17.66	18.52	2.77	11.14	13.26	22.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	JB Chemicals & Pharmaceuticals Ltd	Q V+ PT	1,997	1.15%	32,069 Small Cap	2,195 20 Mar, 26	1,495 06 May, 25	20.17	44.09	8.22	27.84	17.81	19.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Orchid Pharma Ltd	Q V PT	571	1.13%	2,894 Small Cap	898 26 Nov, 25	471 30 Mar, 26	8.04	68.16	2.16	29.90	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	GPT Healthcare Ltd	Q V PT	137	1.03%	1,127 Small Cap	185 01 Aug, 25	114 30 Mar, 26	21.30	27.80	4.28	13.11	13.96	24.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Vimta Labs Ltd	Q V+ PT	478	1.02%	2,134 Small Cap	903 05 Sep, 25	377 30 Mar, 26	19.13	28.56	4.92	14.58	13.74	62.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 Next

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Cohance Lifesciences	391.60	7.80%
RPG Life Sciences	2,025.85	6.63%
IOL Chem & Pharma	91.16	6.62%
Themis Medicare	90.25	5.83%
Park Medi World	216.20	5.57%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Fermenta Biotech	312.55	-2.89%
Sun Pharma Adv. Res	147.90	-2.79%
Wanbury	259.05	-2.59%
Poly Medicure	1,468.25	-1.93%
Yatharth Hospital	754.90	-1.89%

News about BSE Healthcare

Apr, 2026

Apollo Hospitals Enterprise informs about scheme of arrangement

Apollo Hospitals Enterprise has informed that it enclosed update on Order of the Hon'ble National Company Law Tribunal, Division Bench - II, Chennai (Tribunal) in relation to the proposed composite scheme of arrangement.

The above information is a part of company’s filings submitted to BSE.

Apr, 2026

Nectar Lifesciences informs about compliance report

Pursuant to the Regulation 24A of Securities and Exchange of Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 and as amended upto date, Nectar Lifesciences has informed that it attached the Annual Secretarial Compliance Report for the year ended on March 31, 2026, duly signed by Company Secretary in practice.

The above information is a part of company’s filings submitted to BSE.

Apr, 2026

OneSource Specialty Pharma gets EU-GMP renewal for Bengaluru facility

Unit II is a flagship integrated biologics drug-substance and drug-product manufacturing site with capabilities in drug-device combinations and sterile injectable products

Apr, 2026

USFDA completes inspection at Morepen Laboratories’ Masulakhanna facility with Zero observations

This marks the fourth consecutive NIL 483 inspection for Morepen over the past eight years

Apr, 2026

Alembic Pharmaceuticals informs about newspaper advertisement

Alembic Pharmaceuticals has informed that it enclosed paper cuttings of newspaper advertisement issued regarding a Second 100-Day Campaign, launched by Investor Education and Protection Fund Authority (IEPFA) and Ministry of Corporate Affairs (MCA), titled as ‘Saksham Niveshak’ to facilitate Dividend claims and KYC updates published in Indian Express (English Edition) and Financial Express (Gujarati Edition - vernacular language) on 17th April, 2026.

The above information is a part of company’s filings submitted to BSE.

Apr, 2026

Alembic Pharmaceuticals informs about media release

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Methotrexate Injection USP, 50 mg/2 mL (25 mg/mL) Multi-Dose Vials & 1g/40 mL (25 mg/mL) Single-Dose Vials.

The above information is a part of company’s filings submitted to BSE.

BSE Healthcare FAQs

You can use different criterias to arrive at the list of best stocks in the BSE Healthcare company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the BSE Healthcare companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Sun Pharma Advanced Research Company Ltd. (S)	Not Good	148	4,800	0.00	-11.18	-23.68	720
Sanofi Consumer Healthcare India Ltd. (S)	Not Good	4,723	10,876	45.30	28.32	32.07	83.57
Wanbury Ltd. (S)	Very Good	259	905	13.99	7.36	9.98	69.35
Glaxosmithkline Pharmaceuticals Ltd. (M)	Very Good	2,452	41,535	40.68	20.73	28.29	47.10
Procter & Gamble Health Ltd. (S)	Very Good	5,021	8,335	28.40	11.95	19.24	43.64

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,135	61,274	80.92
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,248	63,436	67.55
Emcure Pharmaceuticals Ltd. (S)	Very Good	1,670	31,666	52.58
Granules India Ltd. (S)	Very Good	654	16,216	40.01
Aster DM Healthcare Ltd. (S)	Somewhat Good	688	35,662	37.77
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Health X Platform Ltd. (S)	Not Good	269	856	0.00	3.16	-1205.12	109
Fischer Medical Ventures Ltd. (S)	Not Good	40.80	2,670	0.00	8.30	1,125	96.10
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,310	1,124	22.00	3.61	15.47	46.29
Max Healthcare Institute Ltd. (M)	N/A	1,007	97,991	69.05	9.46	43.39	46.01
Indegene Ltd. (S)	Very Good	487	11,727	26.71	3.95	16.29	34.59

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Yatharth Hospital & Trauma Care Services Ltd. (S)	Very Good	755	7,274	77.75	4.56	46.21	138
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,310	1,124	22.00	3.61	15.47	132
Neuland Laboratories Ltd. (S)	Somewhat Good	15,302	19,632	110	11.89	57.67	64.99
Vimta Labs Ltd. (S)	Very Good	478	2,134	28.56	4.92	14.58	62.65
Max Healthcare Institute Ltd. (M)	N/A	1,007	97,991	69.05	9.46	43.39	60.18

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

BSE Healthcare Companies

News about BSE Healthcare

Apollo Hospitals Enterprise informs about scheme of arrangement

Nectar Lifesciences informs about compliance report

OneSource Specialty Pharma gets EU-GMP renewal for Bengaluru facility

USFDA completes inspection at Morepen Laboratories’ Masulakhanna facility with Zero observations

Alembic Pharmaceuticals informs about newspaper advertisement

Alembic Pharmaceuticals informs about media release

Track Now:

BSE Healthcare FAQs

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

BSE Healthcare Companies

News about BSE Healthcare

Apollo Hospitals Enterprise informs about scheme of arrangement

Nectar Lifesciences informs about compliance report

OneSource Specialty Pharma gets EU-GMP renewal for Bengaluru facility

USFDA completes inspection at Morepen Laboratories’ Masulakhanna facility with Zero observations

Alembic Pharmaceuticals informs about newspaper advertisement

Alembic Pharmaceuticals informs about media release

Track Now:

Trending Blogs

BSE Healthcare FAQs

How to select the top BSE Healthcare stocks based on RoE?

What are the best-performing stocks in the BSE Healthcare index?

Which BSE Healthcare stocks have the highest revenue growth in the past five years?

Which BSE Healthcare stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.